Knott David M Jr »

Protagonist Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2023-09-30 $873k 52k 16.67

More positions owned by Knott David M Jr

Calumet Specialty Products Partners Common (CLMT)
Apollo Global Management Common (APO)
FTAI Aviation Common (FTAI)
Alphabet Inc-Cl C Common (GOOG)
DocGo Common (DCGO)
Midwest Holding Common
Ligand Pharmaceuticals Incorporated Common (LGND)
Ardelyx Common (ARDX)
Coliseum Acquisition Corp. Wts Common (MITAW)
OmniAb Common (OABI)
CALLS/Calumet Specialty Product @20 ex1/24 Common
Franklin BSP Realty Trust Common (FBRT)
Seagen Common
Pfizer Common (PFE)
Panagram BBB-B CLO ETF Common (CLOZ)

View all positions for Knott David M Jr

Top funds holding Protagonist Therapeutics

Farallon Capital Management
BlackRock
BVF
Vanguard Group
Johnson & Johnson
Adage Capital Partners GP
Morgan Stanley
Cowen And Company
Geode Capital Management
Point72 Asset Management
Leucadia National Corporation
Kynam Capital Management
Perceptive Advisors
Marshall Wace
Fairmount Funds Management

View all funds holding Protagonist Therapeutics